
INTRODUCTION
Biopharmaceuticalindustry ofChinadeveloped behind the leading countries, however, it is growing dramaticallyfast during past decades. Chinese government invested in biopharmaceuticals, aswell as made the supporting policies. At present, biopharmaceutical industry isone of the leading industries inChina.
There were 36 listedbiopharmaceutical companies in 2015, the volume of sales reached RMB50.59billion, and the net profit obtained RMB9.24 billion.
Keep pace with thedevelopment of latest biopharmaceutical technologies, this industry dominatedthe whole pharmaceutical industry. Meanwhile, the awareness of health lifestyle of people has changed a lot, which focuses much more on preventionsinstead of therapy treatments. Those factors become incentives to the progressof biopharmaceutical enterprises.
1) TheAim of this report
n To provide readers with comprehensive & in-depthunderstanding ofChina’sbio-pharmaceutical industry;
n To understand the development situation ofbio-pharmaceutical industry inChina;
n Get more information of the major bio-pharmaceuticalproducers inChina;
n Gain insight into the major bio-pharmaceutical producersabout operation;
n To predict what future ofChinabio-pharmaceutical industrywill be;
n To reveal opportunities inChinabio-pharmaceutical industry.
2) Benefitfrom the report
n Financial performance in 2015 and YoY changes, includingrevenue, operating profit, net profit, revenue and gross profit margin frombio-pharmaceutical business;
n Changes of revenue and net profit in the latest five yearsand the reasons;
n Adjustment to business structure in the recent 2-3 years;
n Development strategy anddevelopment trends in the near future.
3) Deliverables
PDF-formatreport, with around 30-50 pages.
4) Timeneeded
Three working days needed.
Part | Contents |
1 | Executive summary |
2 | Ranking of main listed domestic bio-pharmaceutical enterprises in 2015 |
2.1 | List ofChina’s listed bio-pharmaceutical enterprises |
2.2 | By revenue |
2.3 | By net profit |
2.4 | By total assets |
2.5 | By revenue and gross profit margin of bio-pharmaceutical business |
2.6 | By operating profit |
2.7 | By primary earnings per share |
3 | Analysis of listed bio-pharmaceutical enterprises |
3.1 | Jiangsu Sihuan Bioengineering Co., LTD |
3.2 | Hualan Biological Engineering, Inc. |
3.3 | Guilin Layn Natural Ingredients Corp. |
3.4 | Hebei Changshan Biochemical Pharmaceutical Co., Ltd. |
3.5 | Jiangxi Boya Bio-pharmaceutical Co., Ltd. |
3.6 | Beijing Strong Biotechnologies, Inc. |
3.7 | Beijing Tiantan Biological Products Corporation Limited |
3.8 | China Animal Husbandry Industry Co., Ltd. |
3.9 | Shanghai Jiaoda Onlly Co.,Ltd. |
3.10 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. |
3.11 | Shanghai RAAS Blood Products Co., Ltd. |
3.12 | Beijing SL Pharmaceutical Co., Ltd. |
3.13 | Changchun High and New Technology Industry (Group) Inc. |
3.14 | Shenzhen Neptunus Bioengineering Co., Ltd. |
3.15 | Tonghua Dongbao Pharmaceutical Co., Ltd. |
3.16 | Changsheng Bio-technology Co., Ltd. |
3.17 | Sichuan Maccura Biotechnology Co., Ltd. |
3.18 | Zhongyuan Union Cell & Gene Engineering Grop., Ltd. |
3.19 | Shanghai Kehua Bioengineering Co., Ltd. |
3.20 | Staidson (Beijing) Biopharmaceuticals Co., Lt |
3.21 | Chongqing Zhifei Biological Products Co., Ltd. |
3.22 | Beijing Leadman Biochemistry Co., Ltd. |
3.23 | Ningbo Medicalsystem Biotechnology Co., Ltd. |
3.24 | Anhui Anke Biotechnology (Group) Co., Ltd. |
3.25 | Guangzhou Wondfo Biotech Co., Ltd. |
3.26 | Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. |
3.27 | Da An Gene Co., Ltd. ofSunYat-senUniversity |
3.28 | Fujian Cosunter Pharmaceutical Co., Ltd. |
3.29 | Guangdong Vtr Bio-Tech Co., Ltd. |
3.30 | Zhong Zhu Holding Co., Ltd. |
3.31 | Zhenxing Biopharmaceutical and Chemical Co., Ltd. |
3.32 | Zhejiang Qianjiang Biochemical Co., Limited |
3.33 | Ginwa Enterprise (Group) Inc. |
3.34 | Shenzhen Cau Technology Co., Ltd. |
3.35 | Baotou Dongbao Bio-tech Co., Ltd. |
3.36 | Walvax Biotechnology Co., Ltd. |
?本報告所有內容受法律保護,中華人民共和國涉外調查許可證:國統涉外證字第1454號。 本報告由中商產業研究院出品,報告版權歸中商產業研究院所有。本報告是中商產業研究院的研究與統計成果,報告為有償提供給購買報告的客戶內部使用。未獲得中商產業研究院書面授權,任何網站或媒體不得轉載或引用,否則中商產業研究院有權依法追究其法律責任。如需訂閱研究報告,請直接聯系本網站,以便獲得全程優質完善服務。 本報告目錄與內容系中商產業研究院原創,未經本公司事先書面許可,拒絕任何方式復制、轉載。 在此,我們誠意向您推薦鑒別咨詢公司實力的主要方法。
近日,中商產業研究院專家團隊赴滁州市開展《滁州市制造業數字化、網絡化、智能化、綠色化發展的堵點及對策...
近日,中商產業研究院專家團隊赴滁州市開展《滁州市制造業數字化、網絡化、智能化、綠色化發展的堵點及對策...
查看詳情2024年12月27日,昆明市發展和改革委員會組織召開《“十五五”時期提升昆明服務業競爭力對策研究》專家評審...
2024年12月27日,昆明市發展和改革委員會組織召開《“十五五”時期提升昆明服務業競爭力對策研究》專家評審...
查看詳情12月25日,2024年全國農業產業高質量發展大會暨2024年全國農業產業投資推介會在深圳市隆重開幕。此次盛會以...
12月25日,2024年全國農業產業高質量發展大會暨2024年全國農業產業投資推介會在深圳市隆重開幕。此次盛會以...
查看詳情近日,廣東省云浮市政府黨組成員、佛山市-云浮市對口幫扶協作指揮部指揮長,佛云園黨工委書記、管委會主任...
近日,廣東省云浮市政府黨組成員、佛山市-云浮市對口幫扶協作指揮部指揮長,佛云園黨工委書記、管委會主任...
查看詳情近日,湖北省隨州市人民政府黨組成員劉軍偉一行蒞臨我院考察交流,會上劉軍偉介紹了隨州市的產業基礎及現狀...
近日,湖北省隨州市人民政府黨組成員劉軍偉一行蒞臨我院考察交流,會上劉軍偉介紹了隨州市的產業基礎及現狀...
查看詳情12月18日,由貴州省人民政府駐廣州辦事處主辦的省駐粵招商工作基金招商專題培訓會在深圳中商產業研究院項目...
12月18日,由貴州省人民政府駐廣州辦事處主辦的省駐粵招商工作基金招商專題培訓會在深圳中商產業研究院項目...
查看詳情12月13日下午,河北省發展和改革委員會規劃處、人事處組織開展發改大講堂“十五五”規劃編制系列專題培訓,...
12月13日下午,河北省發展和改革委員會規劃處、人事處組織開展發改大講堂“十五五”規劃編制系列專題培訓,...
查看詳情2024年12月9日,內蒙古鄂爾多斯市創新資本招商培訓班在深圳舉辦,中商產業研究院袁健教授應邀為培訓班學員...
2024年12月9日,內蒙古鄂爾多斯市創新資本招商培訓班在深圳舉辦,中商產業研究院袁健教授應邀為培訓班學員...
查看詳情